Position in BMY
as of Jun 30, 2026
· filed Aug 14, 2026
Position Value
$435,722
-$22,913 QoQ
Shares Held
7,562
0.0% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
#1,623
of 2,506 holders
Holding Since
Mar 2020
26 quarters on record
Voting authority
Sole 100%
Shared 0%
None 0%
Common Shares in BMY Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026CHILTON INVESTMENT CO INC. holds $21,642,442 across 10 Drug Manufacturers - General names. BMY ranks #7 (2.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | LLY |
ELI LILLY & Co
|
5,720 | $6,860,740 | |
| 2 | JNJ |
Johnson & Johnson
|
20,745 | $5,268,607 | |
| 3 | ABBV |
AbbVie Inc.
|
16,964 | $4,268,820 | |
| 4 | MRK |
Merck & Co., Inc.
|
13,953 | $1,792,960 | |
| 5 | AMGN |
Amgen Inc
|
3,302 | $1,195,720 | |
| 6 | AZN |
Astrazeneca PLC
|
5,268 | $998,918 | |
| 7 | BMY |
Bristol Myers Squibb Co
This page
|
7,562 | $435,722 | |
| 8 | NVS |
Novartis AG
|
2,250 | $352,620 |
All Filings in BMY
Export CSV
26 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $435,722 | 7,562 | Shares | Sole | 2026-08-14 | |
| 2026-03-31 | $458,635 | 7,562 | Shares | Sole | 2026-05-15 | |
| 2025-12-31 | $515,774 | 9,562 | Shares | Sole | 2026-02-17 | |
| 2025-09-30 | $431,246 | 9,562 | Shares | Sole | 2025-11-14 | |
| 2025-06-30 | $446,791 | 9,652 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $785,612 | 12,881 | Shares | Sole | 2025-05-15 | |
| 2024-12-31 | $544,729 | 9,631 | Shares | Sole | 2025-02-14 | |
| 2024-09-30 | $498,307 | 9,631 | Shares | Sole | 2024-11-14 | |
| 2024-06-30 | $399,975 | 9,631 | Shares | Sole | 2024-08-14 | |
| 2024-03-31 | $522,289 | 9,631 | Shares | Sole | 2024-05-15 | |
| 2023-12-31 | $494,166 | 9,631 | Shares | Sole | 2024-02-14 | |
| 2023-09-30 | $559,099 | 9,633 | Shares | Sole | 2023-11-14 | |
| 2023-06-30 | $686,247 | 10,731 | Shares | Sole | 2023-08-14 | |
| 2023-03-31 | $648,464 | 9,356 | Shares | Sole | 2023-05-15 | |
| 2022-12-31 | $658,774 | 9,156 | Shares | Sole | 2023-02-15 | |
| 2022-09-30 | $650,900 | 9,156 | Shares | Sole | 2022-11-15 | |
| 2022-06-30 | $705,012 | 9,156 | Shares | Sole | 2022-08-16 | |
| 2022-03-31 | $522,602 | 7,156 | Shares | Sole | 2022-05-13 | |
| 2021-12-31 | $446,176 | 7,156 | Shares | Sole | 2022-02-14 | |
| 2021-09-30 | $488,507 | 8,256 | Shares | Sole | 2021-11-05 | |
| 2021-06-30 | $478,163 | 7,156 | Shares | Sole | 2021-08-05 | |
| 2021-03-31 | $451,758 | 7,156 | Shares | Sole | 2021-05-11 | |
| 2020-12-31 | $629,976 | 10,156 | Shares | Sole | 2021-02-11 | |
| 2020-09-30 | $431,435 | 7,156 | Shares | Sole | 2020-11-09 | |
| 2020-06-30 | $644,154 | 10,955 | Shares | Sole | 2020-08-05 | |
| 2020-03-31 | $398,875 | 7,156 | Shares | Sole | 2020-05-06 | |
| No filing history on record for this holder in this stock. | ||||||